Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
T., Rogowski, J., Siebert, J., Wujtewicz, M., Slominska, E
Study Finds Diabetes Medication Reduces Risk Of Death And Heart Disease In People With Arthritis August 12, 2024 (Vancouver) A study conducted by Arthritis Research Canada has revealed that certain diabetes medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1-RAs) like semaglutide (Ozempic), reduced the risk of death and heart attacks in people with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriasis, and lupus, who also have type 2 diabetes
Now, some people are calling retatrutide a GLP-3. What is a GLP-3 and how does it work
Oral Semaglutide for Weight Loss Oral GLP-1 Medications: What You Need to Know Before Deciding Ivm Health is preparing to offer oral semaglutide and other GLP-1 weight loss medications as they become available
